Facebook Linkedin Tumblr Twitter
Sign in
  • My Account
  • orders
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Search
  • Sign in / Join
Facebook Linkedin Tumblr Twitter
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
Market Exclusive #1 Financial News & Analysis Market Exclusive
Market Exclusive #1 Financial News & Analysis
  • My Account
  • orders
Home Biotech Stocks Page 137

Biotech Stocks

Latest
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

Insys Therapeutics Presents Study Results Showing Rapid Absorption Of Epinephrine

ME Staff - February 26, 2019

Veritas Pharma Doses First Subject In Clinical Study Of CTL-X

OWC Pharmaceutical Cannabis Ointment Set To Proceed To PII After Positive PI Data

Reliq Health Technologies Expands Leadership Team As Investigations Continue

Zynerba Gives Clinical Update, Lifelong Impact Of ZYN002

biotech

The Who and What of PD-1 and Janus Kinase Inhibition

- January 6, 2016 0
Bioburden

An Off The Radar Industry With A Billion Dollar Target

Roger Hannington - January 5, 2016 0
FDA

Here are Two Biotech Stocks to Watch in January

Jennifer Aldershot - December 31, 2015 0
Exelixis

The Science Behind Exelixis’ Billion Dollar NDA

Jennifer Aldershot - December 30, 2015 0
biotech

Two Biotech Companies Rated Strong Buys for the New Year

Roger Hannington - December 29, 2015 0
oversold

Post-Holiday Action: Movers and Shakers in Biotech

Jennifer Aldershot - December 28, 2015 0
biotech

Heron’s Big Day Is Just Around The Corner

Jennifer Aldershot - December 23, 2015 0
pSivida

What Medidur’s first success means for pSivida shareholders

Rafi Farber - December 22, 2015 0
biotech

A Look at the Science Behind Bayer’s Latest Buy

Roger Hannington - December 22, 2015 0
biomarin

Could the FDA Approve Both BioMarin and Sarepta’s DMD Candidates?

Roger Hannington - December 17, 2015 0
1...136137138...146Page 137 of 146

Latest Articles

  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

May 11, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

April 27, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

April 7, 2025

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016
biotechnology

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

POPULAR CATEGORY

  • SEC Filings97015
  • Analyst Ratings21747
  • Insider Trading7769
  • Earnings4727
  • LSE4165
  • dividend announcements2433
  • Tech News1583
  • Stocks1511
  • Stock Market News1478
Market Exclusive #1 Financial News & Analysis
ABOUT US
Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.
Contact us: [email protected]
FOLLOW US
Facebook Linkedin Tumblr Twitter
  • SEC Filings
  • Stocks
  • Stock Market News
  • Tech News
  • Biotech Stocks
  • Featured
  • Small Caps
  • gold
  • Other News
  • Oil
  • Become a Contributor!
  • Advertise On Market Exclusive
  • Contact Us
© Market Exclusive 2019